You are here: All Products  > Zai Files for Approval of PARP Inhibitor as First-Line Maintenance Therapy for Ovarian Cancer

Zai Files for Approval of PARP Inhibitor as First-Line Maintenance Therapy for Ovarian Cancer

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products